[RECRUITING] San Francisco, CA — Adults 40–80 with mild memory/thinking changes and higher-than-normal blood sugar — 8-week study

Sponsor: SF Research Institute, Inc.

ClinicalTrials.gov / NCT ID: NCT07220694

ClinicalTrials.gov link: https://clinicaltrials.gov/study/NCT07220694

Phase: Not Applicable

Study overview:

SF Research Institute is enrolling adults for an 8-week research study evaluating Sabroxy®, a plant-based dietary supplement made from a standardized extract of Oroxylum indicum bark, in people with mild cognitive impairment and insulin resistance or higher-than-normal blood sugar.

This is a randomized, double-blind, placebo-controlled study. Participants receive either Sabroxy® or a placebo, and neither the participants nor the study team knows which one is received during the study.

Participants take one capsule daily for approximately 8 weeks and complete scheduled memory/thinking assessments and blood tests.

Eligibility:

You may be eligible if you:

• Are 40–80 years old
• Are a non-smoker
• Have noticed mild changes in memory or thinking, but do not have dementia
• Have higher-than-normal fasting blood sugar, approximately 100–135 mg/dL, or signs of insulin resistance

Additional eligibility criteria apply. Final eligibility is determined by the study team during screening.

Location:

San Francisco Research Institute San Francisco, CA 94132

This is an in-person, single-site study.

Time commitment:

Approximately 8 weeks, including one capsule daily and scheduled study visits.

Compensation:

Compensation information is not listed in the public study record. Participants can ask the study team about compensation or reimbursement during screening.

How to apply:

Review the study information and complete the eligibility form here:

https://hipa.ai/study/NCT07220694

Disclosures:

I am affiliated with this trial: Yes — Hipa.ai provides recruitment support for SF Research Institute.

Recruitment language is IRB-approved: Not applicable — this post is a neutral directory summary based on publicly available ClinicalTrials.gov information and is not presented as sponsor-provided or IRB-approved recruitment copy.

Please do not share diagnoses, medications, contact details, medical records, or other private health information in the comments. Screening takes place through the application link.